Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
2020 · BMC Medicine · 327 citations
https://doi.org/10.1186/s12916-020-01549-2
N
Naixin Liang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
1.2K
Citations
15
h-index
19
i10-index
Naixin Liang is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 15, co-authored 54 publications.
Papers by this author
worksCoexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
2014 · British Journal of Cancer · 237 citations
https://doi.org/10.1038/bjc.2014.210
Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer
2021 · Thoracic Cancer · 13 citations
https://doi.org/10.1111/1759-7714.13942
A novel technique for microwave ablation of malignant pulmonary nodules: electromagnetic navigation bronchoscopy with real-time digital subtraction angiography and computed tomography imaging guidance
2025 · European Journal of Cardio-Thoracic Surgery · 1 citations
https://doi.org/10.1093/ejcts/ezaf063
Additional file 9 of Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13065698
Supplementary Material for: Chemoradiotherapy combined with immunotherapy in stage III non-small cell lung cancer: a systematic review and meta-analysis of efficacy and safety outcomes
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24461302
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat